Drug intelligence / Profile preview

rhodiola crenulata

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Rhodiola crenulata is a perennial herb in the Crassulaceae family, native to high-altitude regions of China, Bhutan, Nepal, Sikkim, and Uzbekistan. It has been used for centuries in Eastern traditional medicine and is described in the Pharmacopoeia of China. Traditionally employed to prevent acute mountain sickness and as an adaptogen to help the body respond to stress and restore normal function, it is also used for improving memory, reducing fatigue and stress (adaptogenic action), stimulating the central nervous system, treating inflammation of the lung and fever, as well as a mouthwash for bad breath[4][5][6]. The main active components are salidroside (present at higher levels than in Rhodiola rosea), tyrosol, pyrogallol, gallic acid, beta-sitosterol, and crenulatin. Preclinical research suggests potential anticancer properties—particularly against aggressive breast tumors—and neuroprotective effects via antioxidant pathways. Mechanistically its constituents may inhibit monoamine oxidases A/B (potential antidepressant effect), modulate cytokines (immune modulation), induce antioxidant enzymes (thioredoxin/heme oxygenase-1/peroxiredoxin-I), downregulate proapoptotic Bax protein while upregulating antiapoptotic Bcl-XL proteins[5][9]. Human clinical data specific to Rhodiola crenulata are limited; most studies focus on related species such as Rhodiola rosea.

Other names
bigflower rhodiola rootda hua hong jing tian rootrhodiola euryphylla root
02

Targets

HIF1A (Hypoxia-inducible factor 1-alpha)

Beyond the preview

Go deeper on rhodiola crenulata.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rhodiola crenulata.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call